{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:17:59Z","timestamp":1790007479111,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003792","name":"Brain Foundation","doi-asserted-by":"publisher","award":["FO2024\\u20130243"],"award-info":[{"award-number":["FO2024\\u20130243"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001858","name":"Sweden's Innovation Agency","doi-asserted-by":"publisher","award":["2021\\u201302640"],"award-info":[{"award-number":["2021\\u201302640"]}],"id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008444","name":"OE and Edla Johanssons Scientific Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2023\\u201301883"],"award-info":[{"award-number":["2023\\u201301883"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["01883"],"award-info":[{"award-number":["01883"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2021\\u201301083"],"award-info":[{"award-number":["2021\\u201301083"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005701","name":"\u00c5hl\u00e9n Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derbergs Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004200","name":"Stiftelsen Olle Engkvist Byggm\u00e4stare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvall Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.biopha.2025.118325","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T20:52:24Z","timestamp":1751921544000},"page":"118325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment"],"prefix":"10.1016","volume":"189","author":[{"given":"Nicole G.","family":"Metzendorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Godec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Chourlia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Napoleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8196-4041","authenticated-orcid":false,"given":"Stina","family":"Syv\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2249-653X","authenticated-orcid":false,"given":"Fadi","family":"Rofo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4136-6792","authenticated-orcid":false,"given":"Greta","family":"Hultqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118325_bib1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3233\/JAD-215008","article-title":"A super-resolved view of the alzheimer\u2019s disease-related amyloidogenic pathway in hippocampal neurons","volume":"83","author":"Yu","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2025.118325_bib2","first-page":"58406","article-title":"\u03b2-amyloid degradation and alzheimer\u2019s disease","volume":"2006","author":"Wang","year":"2006","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.biopha.2025.118325_bib3","doi-asserted-by":"crossref","first-page":"a006379","DOI":"10.1101\/cshperspect.a006379","article-title":"Proteolytic degradation of amyloid \u03b2-protein","volume":"2","author":"Saido","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.biopha.2025.118325_bib4","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1111\/febs.16939","article-title":"Molecular basis of selective amyloid-\u03b2 degrading enzymes in Alzheimer\u2019s disease","volume":"291","author":"\u017bukowska","year":"2024","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2025.118325_bib5","doi-asserted-by":"crossref","first-page":"21895","DOI":"10.1074\/jbc.M008511200","article-title":"Neprilysin Degrades Both Amyloid \u03b2 Peptides 1\u201340 and 1\u201342 Most Rapidly and Efficiently among Thiorphan- and Phosphoramidon-sensitive Endopeptidases","volume":"276","author":"Shirotani","year":"2001","journal-title":"*. J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118325_bib6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/oxfordjournals.jbchem.a022839","article-title":"Biochemical Identification of the Neutral Endopeptidase Family Member Responsible for the Catabolism of Amyloid \u03b2 Peptide in the Brain1","volume":"128","author":"Takaki","year":"2000","journal-title":"J. Biochem. (Tokyo)"},{"key":"10.1016\/j.biopha.2025.118325_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1750-3639.2008.00132.x","article-title":"Abeta-degrading enzymes in Alzheimer\u2019s disease","volume":"18","author":"Miners","year":"2008","journal-title":"Brain Pathol. Zur. Switz."},{"key":"10.1016\/j.biopha.2025.118325_bib8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.molmed.2005.08.004","article-title":"Proteolytic mechanisms in amyloid-beta metabolism: therapeutic implications for Alzheimer\u2019s disease","volume":"11","author":"Vardy","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biopha.2025.118325_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/156720508783954703","article-title":"Neprilysin and amyloid beta peptide degradation","volume":"5","author":"Hersh","year":"2008","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.biopha.2025.118325_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-0102(02)00015-9","article-title":"A\u03b2-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with A\u03b2 pathology","volume":"43","author":"Fukami","year":"2002","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.biopha.2025.118325_bib11","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/srep01472","article-title":"Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice","volume":"3","author":"Iwata","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118325_bib12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7150\/thno.50263","article-title":"Enhanced neprilysin-mediated degradation of hippocampal A\u03b242 with a somatostatin peptide that enters the brain","volume":"11","author":"Rofo","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.118325_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/72237","article-title":"Identification of the major A\u03b21-42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition","volume":"6","author":"Iwata","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2025.118325_bib14","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/jnr.21074","article-title":"Lack of neprilysin suffices to generate murine amyloid-like deposits in the brain and behavioral deficit in vivo","volume":"84","author":"Madani","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.biopha.2025.118325_bib15","doi-asserted-by":"crossref","first-page":"17941","DOI":"10.1074\/jbc.M601372200","article-title":"Neprilysin-sensitive synapse-associated amyloid-\u03b2 peptide oligomers impair neuronal plasticity and cognitive function *","volume":"281","author":"Huang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118325_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3940(00)01675-X","article-title":"Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of \u03b2-amyloid peptide","volume":"297","author":"Yasojima","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2025.118325_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1471-4159.2010.06899.x","article-title":"Expression and functional profiling of neprilysin, insulin degrading enzyme and endothelin converting enzyme in prospectively studied elderly and Alzheimer\u2019s brain","volume":"115","author":"Wang","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2025.118325_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jnr.10390","article-title":"Region-specific reduction of A\u03b2-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging","volume":"70","author":"Iwata","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.biopha.2025.118325_bib19","doi-asserted-by":"crossref","first-page":"15595","DOI":"10.1073\/pnas.1001740107","article-title":"Stabilization of neurotoxic Alzheimer amyloid-\u03b2 oligomers by protein engineering","volume":"107","author":"Sandberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2025.118325_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117715","article-title":"A turn for the worse: A\u03b2 \u03b2-hairpins in Alzheimer\u2019s disease","volume":"105","author":"Ruttenberg","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118325_bib21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nn0901-887","article-title":"The \u2018Arctic\u2019 APP mutation (E693G) causes Alzheimer\u2019s disease by enhanced A\u03b2 protofibril formation","volume":"4","author":"Nilsberth","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2025.118325_bib22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nm1206","article-title":"Somatostatin regulates brain amyloid \u03b2 peptide A\u03b242 through modulation of proteolytic degradation","volume":"11","author":"Saito","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2025.118325_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00096","article-title":"Somatostatin, olfaction, and neurodegeneration","volume":"14","author":"Saiz-Sanchez","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2025.118325_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/288279a0","article-title":"Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa","volume":"288","author":"Davies","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118325_bib25","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1007\/s11064-019-02890-6","article-title":"Somatostatin receptor subtype-4 regulates mRNA expression of amyloid-beta degrading enzymes and microglia mediators of phagocytosis in brains of 3xTg-AD mice","volume":"44","author":"Sandoval","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2025.118325_bib26","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/cercor\/bhz165","article-title":"Preserved calretinin interneurons in an app model of alzheimer\u2019s disease disrupt hippocampal inhibition via upregulated P2Y1 purinoreceptors","volume":"30","author":"Shi","year":"2020","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.biopha.2025.118325_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neurobiolaging.2016.09.006","article-title":"The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy","volume":"49","author":"Soler","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2025.118325_bib28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.7150\/thno.17155","article-title":"Bivalent brain shuttle increases antibody uptake by monovalent binding to the transferrin receptor","volume":"7","author":"Hultqvist","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.118325_bib29","doi-asserted-by":"crossref","first-page":"10759","DOI":"10.1038\/ncomms10759","article-title":"Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer\/\u2019s disease","volume":"7","author":"Sehlin","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118325_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2015.11.024","article-title":"Discovery of novel blood-brain barrier targets to enhance brain uptake of therapeutic antibodies","volume":"89","author":"Zuchero","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2025.118325_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1517\/17425247.2014.952627","article-title":"Blood\u2013brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody","volume":"12","author":"Pardridge","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2025.118325_bib32","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.1c00303","article-title":"Wide-ranging effects on the brain proteome in a transgenic mouse model of alzheimer\u2019s disease following treatment with a brain-targeting somatostatin peptide","author":"Rofo","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2025.118325_bib33","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(03)13555-6","article-title":"Dutch, flemish, italian, and arctic mutations of APP and resistance of A\u03b2 to physiologically relevant proteolytic degradation","volume":"361","author":"Tsubuki","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118325_bib34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13195-022-01132-2","article-title":"Blood\u2013brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer\u2019s disease","volume":"14","author":"Rofo","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.biopha.2025.118325_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.15768","article-title":"A single-chain fragment constant design enables easy production of a monovalent blood-brain barrier transporter and provides an improved brain uptake at elevated doses","author":"Morrison","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2025.118325_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-25965-x","article-title":"Introducing or removing heparan sulfate binding sites does not alter brain uptake of the blood\u2013brain barrier shuttle scFv8D3","volume":"12","author":"de la Rosa","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118325_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13195-018-0377-8","article-title":"Efficient clearance of A\u03b2 protofibrils in A\u03b2PP-transgenic mice treated with a brain-penetrating bifunctional antibody","volume":"10","author":"Syv\u00e4nen","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.biopha.2025.118325_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12987-021-00257-0","article-title":"Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size","volume":"18","author":"Faresj\u00f6","year":"2021","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.biopha.2025.118325_bib39","unstructured":"Metzendorf, N.G., Sehlin, D. & Hultqvist, G. ELISA quantification of different types of amyloid-beta in tissue extracts. (2024)."},{"key":"10.1016\/j.biopha.2025.118325_bib40","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A\u03b2 antibody alters CNS and plasma A\u03b2 clearance and decreases brain A\u03b2 burden in a mouse model of Alzheimer\u2019s disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2025.118325_bib41","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/ijms22031225","article-title":"Anti-parallel \u03b2-hairpin structure in soluble A\u03b2 oligomers of A\u03b240-Dutch and A\u03b240-Iowa","volume":"22","author":"Fu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118325_bib42","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0711731105","article-title":"Stabilization of a \u03b2-hairpin in monomeric Alzheimer\u2019s amyloid-\u03b2 peptide inhibits amyloid formation","volume":"105","author":"Hoyer","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118325_bib43","doi-asserted-by":"crossref","first-page":"29639","DOI":"10.1074\/jbc.R800016200","article-title":"Structural classification of toxic amyloid oligomers *","volume":"283","author":"Glabe","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118325_bib44","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.bbamem.2017.05.012","article-title":"Lipid membranes catalyse the fibril formation of the amyloid-\u03b2 (1\u201342) peptide through lipid-fibril interactions that reinforce secondary pathways","volume":"1859","author":"Lindberg","year":"2017","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"key":"10.1016\/j.biopha.2025.118325_bib45","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/ijms21031129","article-title":"Interaction of A\u03b242 with membranes triggers the self-assembly into oligomers","volume":"21","author":"Banerjee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118325_bib46","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1039\/D0SC02060E","article-title":"Differentiating A\u03b240 and A\u03b242 in amyloid plaques with a small molecule fluorescence probe","volume":"11","author":"Yang","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.biopha.2025.118325_bib47","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/bit.22135","article-title":"Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse","volume":"102","author":"Boado","year":"2009","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biopha.2025.118325_bib48","doi-asserted-by":"crossref","DOI":"10.1186\/s12575-017-0060-7","article-title":"Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells","volume":"19","author":"Fang","year":"2017","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.biopha.2025.118325_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1126\/science.aar5839","article-title":"Quantitative mass imaging of single molecules","volume":"360","author":"Young","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.biopha.2025.118325_bib50","doi-asserted-by":"crossref","first-page":"29362","DOI":"10.1074\/jbc.M112.340372","article-title":"Cell Surface Expression of the Major Amyloid- Peptide (A)-degrading Enzyme, Neprilysin, Depends on Phosphorylation by Mitogen-activated Protein Kinase\/Extracellular Signal-regulated Kinase Kinase (MEK) and Dephosphorylation by Protein Phosphatase","volume":"287","author":"Kakiya","year":"2012","journal-title":"1a. J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118325_bib51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40035-021-00258-x","article-title":"Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta","volume":"10","author":"Rofo","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.biopha.2025.118325_bib52","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1042\/bj0890114","article-title":"The preparation of 131I-labelled human growth hormone of high specific radioactivity","volume":"89","author":"Greenwood","year":"1963","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2025.118325_bib53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neurobiolaging.2004.12.007","article-title":"The Arctic Alzheimer mutation facilitates early intraneuronal A\u03b2 aggregation and senile plaque formation in transgenic mice","volume":"27","author":"Lord","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2025.118325_bib54","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","article-title":"Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death","volume":"40","author":"Leissring","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2025.118325_bib55","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1742-4658.2008.06836.x","article-title":"Amyloid-beta protofibril levels correlate with spatial learning in Arctic Alzheimer\u2019s disease transgenic mice","volume":"276","author":"Lord","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2025.118325_bib56","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1073\/pnas.94.4.1550","article-title":"Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease","volume":"94","author":"Johnson-Wood","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:52:22Z","timestamp":1762311142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225005190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":56,"alternative-id":["S0753332225005190"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118325","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118325"}}